Ownership as of December 30, 2020. Ten largest shareholders.
| Namn | A-aktier | B-aktier | Aktiekapital % | Röster % |
|---|---|---|---|---|
| ANNWALL & ROTHSCHILD INVESTMENTS AB | 377 736 | 410 478 | 7,02 | 28,63 |
| ÖHMAN BANK S.A. | - | 1 174 017 | 10,46 | 8,03 |
| FJÄRDE AP-FONDEN | - | 1 112 919 | 9,91 | 7,61 |
| SWEDBANK ROBUR NY TEKNIK BTI | - | 579 172 | 5,16 | 3,96 |
| AMF AKTIEFOND SMÅBOLAG | - | 501 585 | 4,47 | 3,43 |
| HANDELSBANKEN SVENSKA, SMABOLAGSFOND | - | 450 675 | 4,01 | 3,08 |
| TREDJE AP-FONDEN | - | 438 565 | 3,91 | 3,00 |
| CBNY-NORGES BANK | - | 329 620 | 2,94 | 2,25 |
| UNIONEN | - | 322 196 | 2,87 | 2,20 |
| DANGOOR, DAVID | - | 278 421 | 2,48 | 1,90 |
| Summa 10 största ägare | 377 736 | 5 597 648 | 53,23 | 64,09 |
| Övriga aktieägare | - | 5 250 800 | 46,77 | 35,91 |
| Totalt | 377 736 | 10 848 448 | 100,00 | 100,00 |
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.